Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-063080
Filing Date
2025-06-26
Accepted
2025-06-26 16:56:04
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2519230-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2519230-3_4seq1.xml 4 6737
  Complete submission text file 0001104659-25-063080.txt   8323
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Bedrosian Camille L (Reporting) CIK: 0001326969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 251081097

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)